IPO FILING: Epocrates Inc. (EPOC)

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Updated Published

Epocrates Inc. submitted an SEC filing to come public via an IPO Thursday night. The filing shows a proposed maximum aggregate offering price of $75 million, although this number is for filing purposes only. They applied to trade on the Nasdaq Global Market under the symbol “EPOC.” The underwriters are listed as Citi, Peter Jaffray, William Blair and Company, and Needham & Co.

Epocrates provides medical information support tools to healthcare professional. The company has strong brand recognition and over 500,000 healthcare professionals actively subscribe to use their product, including 1 in 4 doctors and 1 in 3 medical students. The technology allows healthcare professionals to access medical information on various devices, such as Blackberries, Palms, iPhones, desktops and PC’s. The market has seen a growing use of PDA’s or smartphones by physicians and the company believes its strong market position and brand name will create demand for their services. In 2006 and 2007, the company generated $49.5 and $65.6 million, respectively. Income before taxes in 2006 and 2007 were -$1.4 million and $4.6 million, respectively. The company generated enough in 2007 to pull it out of the red and into the green.

Epocrates joins other recent medical industry companies trying to go public. Codexis and Fluidigm also recently submitted their IPO paperwork.

You can join our open email distribution list to hear about other IPO’s, secondary offerings, buybacks, special financings, restructurings and more.

Rachel Lopez
April 18, 2008

Contact [email protected] for any questions or corrections.

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

META Vol: 30,454,989
KMX Vol: 1,353,657
CLX Vol: 1,284,629
NKE Vol: 13,761,029
MOS Vol: 3,803,058

Top Losing Stocks

MRNA Vol: 6,503,359
CTRA Vol: 73,319,495
CRWD Vol: 4,193,266
EPAM Vol: 602,370
FTNT Vol: 1,906,842